Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,302 papers from all fields of science
Search
Sign In
Create Free Account
Maxillary right second molar implant
Known as:
2i
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Increased MAP Kinase Inhibition Enhances Epiblast-Specific Gene Expression in Bovine Blastocysts1
Zachariah L. McLean
,
F. Meng
,
H. Henderson
,
Pavla Turner
,
B. Oback
Biology of Reproduction
2014
Corpus ID: 24535132
ABSTRACT Mammalian blastocysts comprise three distinct lineages, namely, trophoblast, hypoblast, and epiblast, which develop into…
Expand
2012
2012
Simple and efficient derivation of mouse embryonic stem cell lines using differentiation inhibitors or proliferation stimulators.
Kun‐Hsiung Lee
,
C. Chuang
,
Shyh-Forng Guo
,
C. Tu
Stem Cells and Development
2012
Corpus ID: 23021215
The inhibition of endogenous differentiation-inducing signaling or the enhancement of growth capacity and viability of…
Expand
Highly Cited
2005
Highly Cited
2005
Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.
Kwang Seob Lee
,
S. Seo
,
+6 authors
Yong-Sup Lee
Bioorganic & Medicinal Chemistry Letters
2005
Corpus ID: 19571474
2002
2002
Structural basis for unusually long wavelength charge transfer transitions in complexes [MCl(ECH(2)CH(2)NMe(2))(PR(3))] (E = Te, Se; M = Pt, Pd): experimental results and TD-DFT calculations.
S. Dey
,
V. Jain
,
A. Knödler
,
A. Klein
,
W. Kaim
,
S. Záliš
Inorganic Chemistry
2002
Corpus ID: 42227892
A series of new complexes, the blue compounds [PdCl(TeCH(2)CH(2)NMe(2))(PR(3))] (PR(3) = PEt(3), PPr(n)(3), PBu(n)(3), PMe(2)Ph…
Expand
2001
2001
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
F. Carroll
,
Jeffrey R. Lee
,
+5 authors
B. Martin
Journal of Medicinal Chemistry
2001
Corpus ID: 24355188
A number of 2',3'-disubstituted epibatidine analogues were synthesized and evaluated in vitro for potency at nicotinic…
Expand
Review
1998
Review
1998
Investigation of a New Family of Chiral Ligands for Enantioselective Catalysis via Parallel Synthesis and High‐Throughput Screening.
C. Gennari
,
S. Ceccarelli
,
U. Piarulli
,
Christian A. G. N. Montalbetti
,
Richard F. W. Jackson
1998
Corpus ID: 264209955
Applications of combinatorial chemistry are widespread and cover fields as diverse as drug discovery and optimization,1 material…
Expand
Highly Cited
1993
Highly Cited
1993
Inhibition studies of some serine and thiol proteinases by new leupeptin analogues.
R. McConnell
,
J. Lyndal York
,
Donna Frizzell
,
Carole Ezell
Journal of Medicinal Chemistry
1993
Corpus ID: 38595764
Fifteen tripeptide analogues of leupeptin containing either a C-terminal argininal or lysinal were synthesized. The synthetic…
Expand
1990
1990
New leupeptin analogues: synthesis and inhibition data.
Rose M. McConnell
,
Barnes Ge
,
Hoyng Cf
,
Gunn Jm
Journal of Medicinal Chemistry
1990
Corpus ID: 25917722
Syntheses of several tripeptide analogues of leupeptin containing C-terminal argininal, lysinal, or ornithinal units are…
Expand
1979
1979
Tumorigenic activity of 3-methylcholanthrene metabolites on mouse skin and in newborn mice.
W. Levin
,
M. Buening
,
+4 authors
A. Conney
Cancer Research
1979
Corpus ID: 2415931
3-Methylcholanthrene and eight of its metabolites were tested for tumorigenic activity in two tumor models. In the tumorigenicity…
Expand
1955
1955
A Field Test for the Assay of Human Whole-blood Cholinesterase
D. R. Davies
,
J. Nicholls
British medical journal
1955
Corpus ID: 33643259
The level of cholinesterase (ChE) in the blood is a valuable index of the amount of anticholinesterase which has been absorbed…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE